Drug Profile
Research programme: growth factor therapeutics - Branching Tree
Alternative Names: Spinal Bliss; Spinal Bliss - Branching TreeLatest Information Update: 28 Dec 2020
Price :
$50
*
At a glance
- Originator Branching Tree
- Class Growth factors
- Mechanism of Action Growth factor receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Spinal cord disorders
Most Recent Events
- 28 Dec 2020 No recent reports of development identified for preclinical development in Spinal cord disorders in Netherlands
- 02 Nov 2016 Research programme - growth factor therapeutics - Branching Tree is available for licensing as of 02 Nov 2016. http://www.branchingtree.com/Blog/Blog.html (Branching Tree website, November 2016)
- 02 Nov 2016 Branching Tree files for patent protection with for growth factor before November 2016 (Branching Tree website, November 2016)